Description

It’s time for oligonucleotide therapeutics to step into the light. With an increase in therapies in preclinical and clinical stages, many therapeutic developers find that they need to scale up quickly to meet demand. Considering manufacturability and scale-up from small-scale method development will help deliver process efficiency and scalability, ensure smooth technology transfer and save time and materials. In this presentation, we’ll discuss strategies to future-proof your manufacturing for vaccines, therapeutics, and more.

0
Your cart